Mc Glone Suttner Wealth Management, Inc. Sangamo Therapeutics, Inc Transaction History

Mc Glone Suttner Wealth Management, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	SELL	$0.36 - $0.65 $55 - $100	-155 Reduced 1.38%	11,083 $6.02 Million
Q1 2024 Apr 18, 2024	BUY	$0.42 - $1.38 $65 - $213	155 Added 1.4%	11,238 $7.53 Million
Q4 2023 Jan 18, 2024	BUY	$0.3 - $0.63 $3,324 - $6,982	11,083 New	11,083 $6.02 Million

135

86.5M

35.9K

156K

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $319M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Mc Glone Suttner Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Mc Glone Suttner Wealth Management, Inc. with notifications on news.